Increased RhoA Prenylation in the loechrig (loe) Mutant Leads to Progressive Neurodegeneration

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Cook, Mandy ^a   Mani, Priya ^a,b   Wentzell, Jill S ^a,c   Kretzschmar, Doris ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND COMMUNITY COLLEGE   (United States)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; ISOPRENOID; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; GENE MUTATION; LOE GENE; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PATHOGENESIS; PHENOTYPE; PROTEIN FUNCTION; PROTEIN PRENYLATION;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; DROSOPHILA; HYDROXYMETHYLGLUTARYL COA REDUCTASES; MUTATION; NERVOUS SYSTEM; PROTEIN PRENYLATION; RHOA GTP-BINDING PROTEIN;

VERTEBRATA;

EID: 84866128210     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044440     Document Type: Article

References (39)

1. Tschape JA, Hammerschmied C, Muhlig-Versen M, Athenstaedt K, Daum G, et al. (2002) The neurodegeneration mutant lochrig interferes with cholesterol homeostasis and Appl processing. Embo J: 21, 6367-6376.
2. Kemp BE, Mitchelhill KI, Stapleton D, Michell BJ, Chen ZP, et al. (1999) Dealing with energy demand: the AMP-activated protein kinase. Trends Biochem Sci: 24, 22-25.
3. Hardie DG, Carling D, Carlson M (1998) The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu Rev Biochem: 67, 821-855.
4. Hardie DG (2007) AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol: 8, 774-785.
5. Lee JH, Koh H, Kim M, Kim Y, Lee SY, et al. (2007) Energy-dependent regulation of cell structure by AMP-activated protein kinase. Nature: 447, 1017-1020.
6. Mirouse V, Swick LL, Kazgan N, St Johnston D, Brenman JE (2007) LKB1 and AMPK maintain epithelial cell polarity under energetic stress. J Cell Biol: 177, 387-392.
7. Spasic MR, Callaerts P, Norga KK (2008) Drosophila alicorn is a neuronal maintenance factor protecting against activity-induced retinal degeneration. J Neurosci: 28, 6419-6429.
8. McCullough LD, Zeng Z, Li H, Landree LE, McFadden J, et al. (2005) Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke. J Biol Chem: 280, 20493-20502.
9. Burwinkel B, Scott JW, Buhrer C, van Landeghem FK, Cox GF, et al. (2005) Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency. Am J Hum Genet: 76, 1034-1049.
10. Santos AC, Lehmann R (2004) Isoprenoids control germ cell migration downstream of HMGCoA reductase. Dev Cell: 6, 283-293.
11. Holstein SA, Hohl RJ (2004) Isoprenoids: remarkable diversity of form and function. Lipids: 39, 293-309.
12. Seabra MC (1998) Membrane association and targeting of prenylated Ras-like GTPases. Cell Signal: 10, 167-172.
13. Boureux A, Vignal E, Faure S, Fort P (2007) Evolution of the Rho family of ras-like GTPases in eukaryotes. Mol Biol Evol: 24, 203-216.
14. Zhou Y, Su Y, Li B, Liu F, Ryder JW, et al. (2003) Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Abeta42 by inhibiting Rho. Science: 302, 1215-1217.
15. Pedrini S, Carter TL, Prendergast G, Petanceska S, Ehrlich ME, et al. (2005) Modulation of Statin-Activated Shedding of Alzheimer APP Ectodomain by ROCK. PLoS Med: 2, e18.
16. Ostrowski SM, Wilkinson BL, Golde TE, Landreth G (2007) Statins reduce amyloid-beta production through inhibition of protein isoprenylation. J Biol Chem: 282, 26832-26844.
17. Samuel F, Hynds DL (2010) RHO GTPase signaling for axon extension: is prenylation important? Mol Neurobiol: 42, 133-142.
18. Spindler SR, Li R, Dhahbi JM, Yamakawa A, Mote P, et al. (2012) Statin treatment increases lifespan and improves cardiac health in Drosophila by decreasing specific protein prenylation. PLoS One: 7, e39581.
19. Van Doren M, Broihier HT, Moore LA, Lehmann R (1998) HMG-CoA reductase guides migrating primordial germ cells. Nature: 396, 466-469.
20. Spradling AC, Stern D, Beaton A, Rhem EJ, Laverty T, et al. (1999) The Berkeley Drosophila Genome Project gene disruption project: Single P-element insertions mutating 25% of vital Drosophila genes. Genetics: 153, 135-177.
21. Strutt DI, Weber U, Mlodzik M (1997) The role of RhoA in tissue polarity and Frizzled signalling. Nature: 387, 292-295.
22. Lee T, Winter C, Marticke SS, Lee A, Luo L (2000) Essential roles of Drosophila RhoA in the regulation of neuroblast proliferation and dendritic but not axonal morphogenesis. Neuron: 25, 307-316.
23. Carlson CA, Kim KH (1973) Regulation of hepatic acetyl coenzyme A carboxylase by phosphorylation and dephosphorylation. J Biol Chem: 248, 378-380.
24. Steinberg GR, Kemp BE (2009) AMPK in Health and Disease. Physiol Rev: 89, 1025-1078.
25. Zhang FL, Casey PJ (1996) Protein prenylation: molecular mechanisms and functional consequences. Annu Rev Biochem: 65, 241-269.
26. Lowery LA, Van Vactor D (2009) The trip of the tip: understanding the growth cone machinery. Nat Rev Mol Cell Biol: 10, 332-343.
27. Nikolic M (2002) The role of Rho GTPases and associated kinases in regulating neurite outgrowth. Int J Biochem Cell Biol: 34, 731-745.
28. Woo S, Gomez TM (2006) Rac1 and RhoA promote neurite outgrowth through formation and stabilization of growth cone point contacts. J Neurosci: 26, 1418-1428.
29. Tschape JA, Bettencourt da Cruz A, Kretzschmar D (2003) Progressive neurodegeneration in Drosophila: a model system. J Neural Transm Suppl, 51-62.
30. Cole SL, Vassar R (2006) Isoprenoids and Alzheimer's disease: a complex relationship. Neurobiol Dis: 22, 209-222.
31. Novelli G, D'Apice MR (2012) Protein farnesylation and disease. J Inherit Metab Dis.
32. Brand AH, Perrimon N (1993) Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development (Cambridge, England): 118, 401-415.
33. Kretzschmar D, Tschape J, Bettencourt Da Cruz A, Asan E, Poeck B, et al. (2005) Glial and neuronal expression of polyglutamine proteins induce behavioral changes and aggregate formation in Drosophila. Glia: 49, 59-72.
34. Kretzschmar D, Brunner A, Wiersdorff V, Pflugfelder GO, Heisenberg M, et al. (1992) Giant lens, a gene involved in cell determination and axon guidance in the visual system of Drosophila melanogaster. Embo J: 11, 2531-2539.
35. Benzer S (1967) Behavioral mutants of Drosophila isolated by countercurrent distribution. Proc Natl Acad Sci USA 58, 1112-1119.
36. Strauss R, Heisenberg M (1993) A higher control center of locomotor behavior in the Drosophila brain. J Neurosci: 13, 1852-1861.
37. Swanson TL, Knittel LM, Coate TM, Farley SM, Snyder MA, et al. (2005) The insect homologue of the amyloid precursor protein interacts with the heterotrimeric G protein Go alpha in an identified population of migratory neurons. Dev Biol: 288, 160-178.
38. Orgad S, Dudai Y, Cohen P (1987) The protein phosphatases of Drosophila melanogaster and their inhibitors. Eur J Biochem: 164, 31-38.
39. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem: 72, 248-254.